Malignant neoplasm of medulla of adrenal gland
ICD-10 C74.1 is a billable code used to indicate a diagnosis of malignant neoplasm of medulla of adrenal gland.
C74.1 refers to a malignant neoplasm located in the medulla of the adrenal gland, which is responsible for producing catecholamines such as epinephrine and norepinephrine. These hormones play a critical role in the body's response to stress, regulating heart rate, blood pressure, and metabolism. Malignant tumors in this area can lead to excessive hormone production, resulting in symptoms such as hypertension, palpitations, and anxiety. The diagnosis typically involves imaging studies like CT or MRI, along with biochemical tests to assess hormone levels. Treatment options may include surgical resection, chemotherapy, or radiation therapy, depending on the tumor's size, stage, and overall health of the patient. Accurate coding is essential for proper reimbursement and tracking of treatment outcomes, as well as for research purposes in understanding the epidemiology of adrenal malignancies.
Thorough documentation of hormone assays, imaging results, and clinical symptoms.
Patients presenting with hypertension, anxiety, or unexplained weight loss.
Endocrinologists must ensure that all relevant lab results are included to support the diagnosis.
Detailed pathology reports, imaging studies, and treatment plans.
Patients undergoing surgical resection or chemotherapy for adrenal tumors.
Oncologists should document the tumor's response to treatment and any complications.
Used when a biopsy is performed to confirm malignancy.
Pathology report confirming malignancy.
Endocrinologists and oncologists should ensure biopsy results are documented in the patient's record.
Common symptoms include hypertension, palpitations, sweating, and anxiety due to excess catecholamine production.
Diagnosis typically involves imaging studies such as CT or MRI, along with biochemical tests to measure catecholamine levels.
Treatment may include surgical resection, chemotherapy, or radiation therapy, depending on the tumor's characteristics and stage.
